Providing insights into the genetic and molecular basis of disease.
IGMM Mass Spectrometry is a facility for measuring molecules from biological and clinical samples. We enable researchers to study changes in the amounts of proteins, lipids, metabolites and other molecules in cells and tissues, as well as tracing atoms through metabolic pathways, examining protein-protein interactions, and exploring signalling networks.
The IGMM houses cutting edge protein and antibody microarray facilities for the analysis of complex signaling pathways and secreted factors (e.g. chemokines/cytokines) across multiple pre-clinical and clinical sample types. Our facility brings together industry leading platforms, like the high throughput Aushon 2470 microarrayer, the Innopsys 710 infra-red microarray scanner, and the zeptosens RPPA system.
The technologies we offer in this facility are:
• Reverse Phase Protein Arrays
• Forward Phase Antibody Microarrays